Elacridar hydrochloride

• Description:

  A potent inhibitor of multidrug resistance (MDR) that fully reverses multidrug resistance CHRC5, OV1/DXR and MCF7/ADR cells to the cytotoxicity of doxorubicin and vincristine with IC50 of 0.02 uM.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  600.1039

• Molecular Formula:

  C34H34ClN3O5

• Notes:

  Research use only, not for human use.

• Receptor:

  P-glycoprotein

• CAS Number:

  143851-98-3